Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-12-04Clinical Trial Update: Stem Cell Implantation in Patients Undergoing CABG [Phase 1]
A Phase 1 trial evaluating stem cell implantation in patients undergoing CABG was terminated; Miltenyi Biotec is the sponsor.
-
CLINICAL_TRIALS withdrawal · 2013-11-20Clinical Trial Update: Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Therapy After Drug Eluting Stent Placement
A clinical trial evaluating the optimal length of anti-platelet therapy after drug-eluting stent placement, using intravascular optical cohe…
-
CLINICAL_TRIALS withdrawal · 2013-10-23Clinical Trial Update: Coronary Vasomotor Response After Riociguat Exposure [Phase 2]
A Phase 2 trial evaluating coronary vasomotor response after riociguat exposure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-05Clinical Trial Update: Lipid Rich Necrotic Core Lesion Detected by Cardiac Magnetic Resonance Imaging (CMR) [NA]
The trial evaluating lipid-rich necrotic core lesions detected by cardiac MRI in coronary artery disease has been withdrawn. No results are …
-
CLINICAL_TRIALS withdrawal · 2013-07-01Clinical Trial Update: Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases [NA]
The clinical trial evaluating the CADence System for detecting coronary artery disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-05-30Clinical Trial Update: Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI [Phase 3]
A Phase 3 open-label trial evaluating Flurpiridaz F-18 PET MPI versus SPECT MPI for coronary artery disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-04Clinical Trial Update: A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)
A long-term follow-up study evaluating the predictive value of BMS747158 in patients suspected of coronary artery disease has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2013-03-14Clinical Trial Update: 320 Multidetector Computed Tomography Prior to Coronary Artery Bypass Surgery
The University of Edinburgh-sponsored trial evaluating 320-slice multidetector computed tomography before coronary artery bypass surgery has…
-
CLINICAL_TRIALS withdrawal · 2013-01-29Clinical Trial Update: Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)
A trial evaluating rosuvastatin for secondary prevention in patients undergoing elective percutaneous coronary intervention has been termina…
-
CLINICAL_TRIALS withdrawal · 2012-12-11Clinical Trial Update: Registry for CARDIAC PERFUSION CT
Registry entry for CARDIAC PERFUSION CT (NCT01346605) sponsored by MDDX LLC has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-21Clinical Trial Update: Coronary Artery and Coronary Artery Bypass Graft Imaging Using a Specialized Catheter and Computed Tomography [Phase 1]
A Phase 1 clinical trial evaluating imaging of the coronary arteries and coronary artery bypass grafts with a specialized catheter and compu…
-
CLINICAL_TRIALS withdrawal · 2012-07-31Clinical Trial Update: A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM) [Phase 4]
Phase 4 trial evaluating the effects of ranolazine on exercise duration in patients with chronic stable angina and coronary artery disease w…
-
CLINICAL_TRIALS withdrawal · 2012-05-07Clinical Trial Update: RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)
This document reports that the RIAPRE non-interventional registry of anticoagulation treatment (BI-006-IT) sponsored by Nycomed has been wit…
-
CLINICAL_TRIALS withdrawal · 2009-11-03Clinical Trial Update: A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN) [Phase 2]
A Phase 2 safety and efficacy trial evaluating fondaparinux in percutaneous coronary intervention has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2008-07-03Clinical Trial Update: Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease [Phase 3]
A Phase 3 safety and efficacy trial of PB127 ultrasound contrast agent for diagnosing coronary artery disease has been terminated.
-
CLINICAL_TRIALS withdrawal · 2006-11-30Clinical Trial Update: Cell Therapy for Coronary Heart Disease [Phase 2]
A Phase 2 clinical trial evaluating a cell therapy for coronary artery disease was terminated.